Andrew Dudum - 07 Aug 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
07 Aug 2025
Net transactions value
-$33,384,120
Form type
4
Filing time
11 Aug 2025, 17:07:29 UTC
Previous filing
23 Jul 2025
Next filing
20 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dudum Andrew Chief Executive Officer, Director, 10%+ Owner 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 11 Aug 2025 0001837796

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale $33,384,120 -660,000 -23% $50.58 2,214,769 07 Aug 2025 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 F1
holding HIMS Class A Common Stock 92,313 07 Aug 2025 Direct
holding HIMS Class A Common Stock 1,194,545 07 Aug 2025 Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
holding HIMS Class A Common Stock 990,410 07 Aug 2025 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 1,286,627 07 Aug 2025 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 534,491 07 Aug 2025 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 186,723 07 Aug 2025 Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025
holding HIMS Class A Common Stock 190,126 07 Aug 2025 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 321,657 07 Aug 2025 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 1,584,506 07 Aug 2025 Held by Trustee of AD 2023 GRAT dated 9-5-2023
holding HIMS Class A Common Stock 829,185 07 Aug 2025 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.25 - $51.125. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.